XtalPi Holdings Limited, an investment holding company, provides drug discovery and intelligent automation solutions in China, the United States, Europe, South Korea, and Japan. The company’s drug discovery solutions cover the whole drug discovery and research process, including target validation, hit identification, lead generation, lead optimization, and PCC nomination covering various modalities, which comprise small molecules, antibodies, peptides, ADC, and PROTAC. Its intelligent automation solutions focus on AI- and automation-enabled novel drug and materials discovery and research. The company was formerly known as QuantumPharm Inc. and changed its name to XtalPi Holdings Limited in December 2024. XtalPi Holdings Limited was founded in 2015 and is headquartered in Shenzhen, China.
Metrics to compare | 2228 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2228PeersSector | |
---|---|---|---|---|
P/E Ratio | −7.8x | −3.0x | −0.5x | |
PEG Ratio | - | 0.06 | 0.00 | |
Price/Book | 4.8x | 2.5x | 2.6x | |
Price / LTM Sales | 101.1x | 5.3x | 3.0x | |
Upside (Analyst Target) | 23.8% | −0.5% | 55.3% | |
Fair Value Upside | Unlock | 11.7% | 9.8% | Unlock |